BioPharma Dive 2025年12月8日 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 2025年12月8日 Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
BioPharma Dive 2025年12月5日 Hemophilia gene therapies are struggling on the market, even as innovation soars
BioPharma Dive 2025年12月3日 After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis